MORGAN STANLEY - EVAXION BIOTECH A S ownership

EVAXION BIOTECH A S's ticker is EVAX and the CUSIP is 29970R105. A total of 8 filers reported holding EVAXION BIOTECH A S in Q3 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of EVAXION BIOTECH A S
ValueSharesWeighting
Q3 2023$2,871
-36.4%
3,4460.0%0.00%
Q2 2023$4,514
-89.0%
3,446
-90.5%
0.00%
Q1 2023$40,946
+524.2%
36,235
+880.4%
0.00%
Q4 2022$6,560
-34.4%
3,6960.0%0.00%
Q3 2022$10,000
+25.0%
3,696
-14.0%
0.00%
Q2 2022$8,000
-69.2%
4,296
-48.6%
0.00%
Q1 2022$26,000
+62.5%
8,357
+126.1%
0.00%
Q4 2021$16,000
+700.0%
3,696
+1748.0%
0.00%
Q3 2021$2,000
+100.0%
200
+100.0%
0.00%
Q1 2021$1,0001000.00%
Other shareholders
EVAXION BIOTECH A S shareholders Q3 2022
NameSharesValueWeighting ↓
Beacon Capital Management, LLC 6,881$9,0140.00%
Moloney Securities Asset Management, LLC 11,000$9,1630.00%
GROUP ONE TRADING, L.P. 386$3320.00%
MORGAN STANLEY 3,446$2,8710.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11,000$9,4600.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 32,774$28,1860.00%
TWO SIGMA SECURITIES, LLC 15,188$12,6520.00%
AE Wealth Management LLC 48,633$40,5110.00%
JPMORGAN CHASE & CO 9,283$7,9830.00%
UBS Group AG 4,005$3,3360.00%
View complete list of EVAXION BIOTECH A S shareholders